• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敏感性分析在发现潜在分子药物靶标中的应用。

Application of Sensitivity Analysis to Discover Potential Molecular Drug Targets.

机构信息

Department of Biosensors and Processing of Biomedical Signals, Silesian University of Technology, 41-800 Zabrze, Poland.

Department of Systems Biology and Engineering, Silesian University of Technology, 44-100 Gliwice, Poland.

出版信息

Int J Mol Sci. 2022 Jun 13;23(12):6604. doi: 10.3390/ijms23126604.

DOI:10.3390/ijms23126604
PMID:35743048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9223434/
Abstract

Mathematical modeling of signaling pathways and regulatory networks has been supporting experimental research for some time now. Sensitivity analysis, aimed at finding model parameters whose changes yield significantly altered cellular responses, is an important part of modeling work. However, sensitivity methods are often directly transplanted from analysis of technical systems, and thus, they may not serve the purposes of analysis of biological systems. This paper presents a novel sensitivity analysis method that is particularly suited to the task of searching for potential molecular drug targets in signaling pathways. Using two sample models of pathways, p53/Mdm2 regulatory module and IFN-β-induced JAK/STAT signaling pathway, we show that the method leads to biologically relevant conclusions, identifying processes suitable for targeted pharmacological inhibition, represented by the reduction of kinetic parameter values. That, in turn, facilitates subsequent search for active drug components.

摘要

目前,信号通路和调控网络的数学建模已经在为一些实验研究提供支持。敏感性分析旨在找到那些模型参数发生变化会显著改变细胞反应的参数,这是建模工作的重要组成部分。然而,敏感性分析方法通常是直接从技术系统分析中移植过来的,因此,它们可能并不适用于生物系统的分析。本文提出了一种新的敏感性分析方法,特别适合于在信号通路中寻找潜在的分子药物靶点。我们使用了两个通路的模型,即 p53/Mdm2 调控模块和 IFN-β诱导的 JAK/STAT 信号通路,表明该方法可以得出具有生物学意义的结论,确定适合靶向药理抑制的过程,即通过降低动力学参数值来实现。这反过来又有助于后续寻找有效的药物成分。

相似文献

1
Application of Sensitivity Analysis to Discover Potential Molecular Drug Targets.敏感性分析在发现潜在分子药物靶标中的应用。
Int J Mol Sci. 2022 Jun 13;23(12):6604. doi: 10.3390/ijms23126604.
2
Complex systems biology approach to understanding coordination of JAK-STAT signaling.运用复杂系统生物学方法理解JAK-STAT信号传导的协调机制。
Biosystems. 2007 Nov-Dec;90(3):830-42. doi: 10.1016/j.biosystems.2007.05.005. Epub 2007 Jun 14.
3
In silico identification of the key components and steps in IFN-gamma induced JAK-STAT signaling pathway.干扰素-γ诱导的JAK-STAT信号通路关键成分和步骤的计算机模拟鉴定
FEBS Lett. 2005 Feb 14;579(5):1101-8. doi: 10.1016/j.febslet.2005.01.009.
4
A simple work flow for biologically inspired model reduction--application to early JAK-STAT signaling.一种用于生物启发式模型简化的简单工作流程——应用于早期JAK-STAT信号传导
BMC Syst Biol. 2011 Feb 21;5:30. doi: 10.1186/1752-0509-5-30.
5
Petri nets and ODEs as complementary methods for comprehensive analysis on an example of the ATM-p53-NF-[Formula: see text]B signaling pathways.Petri 网和 ODE 作为互补方法的综合分析示例的 ATM-p53-NF-[Formula: see text]B 信号通路。
Sci Rep. 2022 Jan 21;12(1):1135. doi: 10.1038/s41598-022-04849-0.
6
Model-based selection of the robust JAK-STAT activation mechanism.基于模型的稳健 JAK-STAT 激活机制选择。
J Theor Biol. 2012 Sep 21;309:34-46. doi: 10.1016/j.jtbi.2012.04.031. Epub 2012 Jun 5.
7
Modeling regulatory mechanisms in IL-6 signal transduction in hepatocytes.肝细胞中白细胞介素-6信号转导调控机制的建模
Biotechnol Bioeng. 2006 Dec 5;95(5):850-62. doi: 10.1002/bit.21026.
8
Novel recurrent neural network for modelling biological networks: oscillatory p53 interaction dynamics.用于生物网络建模的新型递归神经网络:振荡性p53相互作用动力学
Biosystems. 2013 Dec;114(3):191-205. doi: 10.1016/j.biosystems.2013.08.004. Epub 2013 Sep 5.
9
Boolean network modeling in systems pharmacology.系统药理学中的布尔网络建模。
J Pharmacokinet Pharmacodyn. 2018 Feb;45(1):159-180. doi: 10.1007/s10928-017-9567-4. Epub 2018 Jan 6.
10
Mathematical formalisms based on approximated kinetic representations for modeling genetic and metabolic pathways.基于近似动力学表示的数学形式主义,用于遗传和代谢途径建模。
Biotechnol Genet Eng Rev. 2008;25:1-40. doi: 10.5661/bger-25-1.

引用本文的文献

1
Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways.表皮生长因子诱导的丝裂原激活蛋白激酶细胞信号通路的数学建模与推断。
Int J Mol Sci. 2024 Sep 23;25(18):10204. doi: 10.3390/ijms251810204.
2
Mathematical Modeling Support for Lung Cancer Therapy-A Short Review.肺癌治疗的数学建模支持——简要综述。
Int J Mol Sci. 2023 Sep 25;24(19):14516. doi: 10.3390/ijms241914516.
3
Mathematical modeling of regulatory networks of intracellular processes - Aims and selected methods.

本文引用的文献

1
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.RNA 药物和小分子的 RNA 靶点:原理、进展与挑战。
Pharmacol Rev. 2020 Oct;72(4):862-898. doi: 10.1124/pr.120.019554.
2
Treatment of SARS-CoV-2: How far have we reached?新型冠状病毒肺炎的治疗:我们已经取得了多大进展?
Drug Discov Ther. 2020 May 6;14(2):67-72. doi: 10.5582/ddt.2020.03008. Epub 2020 Apr 25.
3
Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02.干扰素-β使人类胶质母细胞瘤细胞对细胞周期蛋白依赖性激酶抑制剂TG02敏感。
细胞内过程调控网络的数学建模——目标与选定方法
Comput Struct Biotechnol J. 2023 Feb 8;21:1523-1532. doi: 10.1016/j.csbj.2023.02.006. eCollection 2023.
Oncol Lett. 2020 Apr;19(4):2649-2656. doi: 10.3892/ol.2020.11362. Epub 2020 Jan 30.
4
Strategies to Support Fragment-to-Lead Optimization in Drug Discovery.支持药物发现中片段到先导物优化的策略。
Front Chem. 2020 Feb 18;8:93. doi: 10.3389/fchem.2020.00093. eCollection 2020.
5
Multi-parameter exploration of dynamics of regulatory networks.调控网络动力学的多参数探索
Biosystems. 2020 Apr;190:104113. doi: 10.1016/j.biosystems.2020.104113. Epub 2020 Feb 10.
6
Assessment of CCL27 and IL-11 in Multiple Sclerosis Patients Treated with Interferon-β and Glatiramer Acetate.用干扰素-β和醋酸格拉替雷治疗的多发性硬化症患者中CCL27和IL-11的评估
Neuroimmunomodulation. 2019;26(6):301-306. doi: 10.1159/000505098. Epub 2020 Jan 14.
7
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.比较瑞德西韦与洛匹那韦利托那韦和干扰素β联合治疗中东呼吸综合征冠状病毒的疗效。
Nat Commun. 2020 Jan 10;11(1):222. doi: 10.1038/s41467-019-13940-6.
8
MDM2 inhibition-mediated autophagy contributes to the pro-apoptotic effect of berberine in p53-null leukemic cells.MDM2 抑制介导的自噬有助于小檗碱在 p53 缺失白血病细胞中诱导细胞凋亡。
Life Sci. 2020 Feb 1;242:117228. doi: 10.1016/j.lfs.2019.117228. Epub 2019 Dec 24.
9
Long-term Outcome of Schilder Disease Treated With Interferon-β.Schilder 病采用干扰素-β治疗的长期疗效。
Pediatrics. 2019 Nov;144(5). doi: 10.1542/peds.2019-0505.
10
IFN- signalling regulates RAW 264.7 macrophage activation, cytokine production, and killing activity.IFN- 信号转导调节 RAW 264.7 巨噬细胞的活化、细胞因子的产生和杀伤活性。
Innate Immun. 2020 Apr;26(3):172-182. doi: 10.1177/1753425919878839. Epub 2019 Oct 15.